Twitter summary: BI/Lilly launch Jardiance in the US, making it the 3 rd SGLT-2 inhibitor on the market; savings program for one-year free supply After its recent FDA...

On May 20, the Diabetes Technology Society (DTS) announced the launch of a post-market blood glucose monitoring surveillance program , which will aim to assess and...

Twitter summary: Apple unveils smart watch with several sleek fitness apps – available early 2015 starting at $349 On September 9, Apple unveiled its first-ever smart...

At the 2014 American Diabetes Association conference, Maria Isabel Garcia, NP presented preliminary data from Project Dulce’s text-messaging based intervention, “Dulce...

Twitter summary: Lilly’s new basal #insulin Peglispro superior to Sanofi’s Lantus in A1c reduction, though some potential liver safety and hypo concerns On September 4,...

On July 15, Novartis announced a partnership with Google[x] to develop smart contact lenses that can non-invasively track blood glucose levels through tears and send the...

Twitter Summary: Abbott receives EU Approval to launch Freestyle Libre – updates from EASD on payment, device accuracy, design, and user experience On September 3,...

Getting to goal – the four biggest game-changers for improving my diabetes management.

Twitter: Livongo for Diabetes cloud-connected meter connects users to virtual care team, has algorithm-based feedback and built-in activity monitor Livongo Health...

We’ve been following the development of Lilly’s Trulicity (dulaglutide), a once-weekly GLP-1 receptor agonist , for almost two years now, so it was encouraging to hear...

Incredible enthusiasm continues for the 14-day sensor that replaces fingersticks.

Submitted to the FDA and could be approved this year.

How this two-week trial looks to bring the Libre technology to health care.

What this dramatic movement in obesity therapy means for patients in Europe.

Twitter summary: UCSF launches SugarScience, an initiative on sugar’s dangerous health impacts. Visit SugarScience.org for more information A group of health scientists...

14-day sensor to replace glucose meters, but provide CGM-like info. Now available in Europe. When is it coming to the US? Read more for our full experience testing this...

Larger capacity reservoir will bring pump therapy to those with high insulin needs.

Our deep dive on a new therapy now available in Europe – the benefits, risks, and when it might come to the US.

Major A1c improvements, weight loss, and no injections!

First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?